Nexalin Technology, Inc..
NXL.US | Manufacture of medical and dental instruments and supplies
Nexalin Technology, Inc. is a medical device company focused on developing and commercializing neurostimulation devices. Their primary product, the Nexalin System, is a non-invasive brain stimulation technology that uses a proprietary waveform to modulate neural activity. The company targets the tre...Show More
Better Health for All
-10
Nexalin Technology's core products, non-invasive neurostimulation devices and an AI-driven virtual clinic, are entirely devoted to improving health outcomes for mental health and neurological disorders such as depression, insomnia, Alzheimer's, PTSD, TBI, and addiction.
1
Clinical trials show a 65-66% response rate in depression, which is higher than the 50% average for traditional antidepressants, and reported symptom reduction of 60-80% in patient surveys.
2
The treatment is FDA cleared, non-invasive, has no side effects, and its safety is supported by 14 peer-reviewed studies.
3
The company launched its AI-driven virtual clinic, NeuroCare®, on February 5, 2026, which is described as a transformative step toward making mental health treatment more accessible.
4
Nexalin is strategically focused on PTSD, TBI, and addiction research for veterans, collaborating with UC San Diego and the San Diego VA.
5
The company has initiated, completed, or is actively conducting 29 Institutional Review Board (IRB)-approved clinical trials.
6
However, the company's press releases heavily rely on optimistic forward-looking statements, and its forward-looking statements are subject to numerous conditions and risks, as noted in its SEC filings.
7
While the virtual clinic utilizes an Electronic Data Capture platform and Patient Monitoring System, there is no information on privacy safeguards or data breach history.
8
The company addresses the global mental health crisis, but there is no evidence of specific actions taken during public health emergencies or donations.
9
Fair Money & Economic Opportunity
0
No evidence available to assess Nexalin Technology, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No sufficient, company-wide, quantitative evidence was found across the provided articles to score any of the KPIs for Fair Pay & Worker Respect. While an executive's employment agreement details a fixed three-year term with automatic renewals and health benefits for officers, this does not provide data for the entire workforce.
1
An older, single anonymous employee review (from 2015) stated no benefits were offered, but this is not comprehensive or recent enough to apply broadly.
2
The company's Code of Business Conduct and Ethics outlines policies for fair dealing, anti-retaliation, and a whistleblower policy, but these are statements of intent and policy, not evidence of specific outcomes or metrics like living wage coverage, pay ratios, collective bargaining, safety incident rates, pay equity, worker engagement, turnover, labor violations, insecure contract share, or health insurance coverage for the general workforce.
3
CEO compensation is mentioned, but median employee compensation is not, preventing calculation of a pay ratio.
4
Several articles explicitly state a lack of data for these social and labor metrics.
5
Fair Trade & Ethical Sourcing
0
No specific, concrete data points or information relevant to Nexalin Technology's fair trade and ethical sourcing practices, supply chain audits, forced/child labor incidents, traceability, remediation speed, ethical clauses in contracts, materials risk, or supplier diversity spend were found in the provided articles.
1
All articles explicitly state a lack of relevant data for assessment.
Honest & Fair Business
0
No specific, quantifiable evidence was found in the provided articles to assess Nexalin Technology, Inc. against any of the defined KPIs for the 'Honest & Fair Business' value. The articles mention the availability of a Whistleblower Policy, Code of Ethics, Audit Committee Charter, Compensation Committee Charter, and Nominating and Corporate Governance documents for download.
1
They also discuss areas of regulatory oversight and the importance of robust anti-corruption policies and transparency.
2
However, they do not provide concrete data points such as regulatory fine amounts, transparency index scores, financial restatement numbers, audit coverage percentages, ESG controversy scores, complaint resolution times, board conflict-free percentages, or details on the strength and enforcement of anti-corruption policies or third-party verification of ethical claims.
3
Kind to Animals
0
Nexalin Technology Inc. is identified as having 'No Animal Exploitation'.
1
This indicates that the company does not engage in animal testing, use animal-derived ingredients, or operate animal husbandry facilities. Consequently, all related animal welfare KPIs are not applicable to its operations.
No War, No Weapons
0
No evidence available to assess Nexalin Technology, Inc. on No War, No Weapons.
Planet-Friendly Business
-20
The company's Code of Business Conduct and Ethics, effective May 20, 2022, outlines a policy to conduct business in an environmentally responsible way, minimizing environmental impacts and risks.
1
It commits to reducing waste generation and disposing of waste safely.
2
No specific regulatory actions, violations, fines, or compliance issues are mentioned in the provided articles, indicating an absence of reported violations.
3
Respect for Cultures & Communities
0
No specific, concrete evidence was found in the provided articles to assess Nexalin Technology, Inc. against any of the KPIs for the 'Respect for Cultures & Communities' value. The articles primarily focus on product launches, business partnerships, and internal governance documents, without providing data on community engagement, cultural impact, or local investment.
Safe & Smart Tech
0
While Nexalin Technology, Inc. operates an AI-driven virtual clinic
1
and its neurostimulation devices process sensitive patient data,
2
the provided articles do not contain specific, concrete evidence to score any of the 'Safe & Smart Tech' KPIs. There is no information regarding data breaches, AI ethics governance, cybersecurity investment, privacy certifications, encryption implementation details, or any other specific metrics outlined in the rubric. The articles mention the company is subject to regulatory oversight like HIPAA
3
and that patient data is 'securely uploaded to the cloud,'
4
but do not provide evidence of its compliance program's effectiveness, specific security measures, or actions taken that align with the quantitative thresholds of the KPIs.
Zero Waste & Sustainable Products
0
The provided articles focus on Nexalin Technology Inc.'s financial performance, clinical trial progress, and legislative support. They do not contain specific, concrete data points or information regarding waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certifications, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education programs.
1